Gritstone Oncology, Inc.
Gritstone Oncology, Inc. (GRTS) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 91 transactions totaling $16.4M, demonstrating a bullish sentiment with $13.7M in net insider flow. The most recent transaction on Jun 24, 2024 involved a transaction of 325,000 shares valued at $0.
GRTS Insider Activity Summary
Who Is Buying GRTS Stock?
No significant insider buying has been recorded for GRTS in the recent period.
Who Is Selling GRTS Stock?
No significant insider selling has been recorded for GRTS in the recent period.
Is Gritstone Oncology, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GRTS is bullish with an Insider Alignment Score of 92/100 and a net flow of $13.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
GRTS Frequently Asked Questions
Understanding GRTS Insider Activity
Insider trading at Gritstone Oncology, Inc. (GRTS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading GRTS stock, having executed 91 transactions in the past 90 days. The most active insider is Thomas Woiwode (Executive), who has made 8 transactions totaling $5.0M.
Related Tools
Track Gritstone Oncology, Inc. Insider Activity
Get notified when executives and directors at GRTS file new Form 4 transactions